SE544843C2 - Plant extracts for treatment of rosacea - Google Patents

Plant extracts for treatment of rosacea

Info

Publication number
SE544843C2
SE544843C2 SE1930415A SE1930415A SE544843C2 SE 544843 C2 SE544843 C2 SE 544843C2 SE 1930415 A SE1930415 A SE 1930415A SE 1930415 A SE1930415 A SE 1930415A SE 544843 C2 SE544843 C2 SE 544843C2
Authority
SE
Sweden
Prior art keywords
extract
alpinia officinarum
pharmaceutical formulation
myricetin
rosacea
Prior art date
Application number
SE1930415A
Other languages
English (en)
Swedish (sv)
Other versions
SE1930415A1 (en
Inventor
Christina Österlund
Ia Khmaladze
Lene Visdal-Johnsen
Michele Leonardi
Nahid Amini
Nina Hrapovic
Susanne Fabre
Virginie Lafon-Kolb
Original Assignee
Oriflame Cosmetics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oriflame Cosmetics Ag filed Critical Oriflame Cosmetics Ag
Priority to SE1930415A priority Critical patent/SE544843C2/en
Priority to CN202080079455.0A priority patent/CN115209868A/zh
Priority to EP20807385.8A priority patent/EP4081181A1/fr
Priority to PCT/EP2020/082154 priority patent/WO2021129977A1/fr
Publication of SE1930415A1 publication Critical patent/SE1930415A1/en
Publication of SE544843C2 publication Critical patent/SE544843C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9062—Alpinia, e.g. red ginger or galangal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE1930415A 2019-12-23 2019-12-23 Plant extracts for treatment of rosacea SE544843C2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE1930415A SE544843C2 (en) 2019-12-23 2019-12-23 Plant extracts for treatment of rosacea
CN202080079455.0A CN115209868A (zh) 2019-12-23 2020-11-13 用于治疗面部血管分布提高的植物提取物
EP20807385.8A EP4081181A1 (fr) 2019-12-23 2020-11-13 Extraits végétaux destinés au traitement d'une vascularité accrue du visage
PCT/EP2020/082154 WO2021129977A1 (fr) 2019-12-23 2020-11-13 Extraits végétaux destinés au traitement d'une vascularité accrue du visage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1930415A SE544843C2 (en) 2019-12-23 2019-12-23 Plant extracts for treatment of rosacea

Publications (2)

Publication Number Publication Date
SE1930415A1 SE1930415A1 (en) 2021-06-24
SE544843C2 true SE544843C2 (en) 2022-12-13

Family

ID=73449090

Family Applications (1)

Application Number Title Priority Date Filing Date
SE1930415A SE544843C2 (en) 2019-12-23 2019-12-23 Plant extracts for treatment of rosacea

Country Status (4)

Country Link
EP (1) EP4081181A1 (fr)
CN (1) CN115209868A (fr)
SE (1) SE544843C2 (fr)
WO (1) WO2021129977A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
US20030105031A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Methods for the treatment of skin disorders
US7105172B1 (en) * 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
US7381433B1 (en) * 2007-01-08 2008-06-03 Johnson & Johnson Consumer Companies, Inc. Compositions containing an extract of a primula denticulata and use thereof
CN106821865A (zh) * 2017-03-25 2017-06-13 广州市聚吉科绿色化学共性技术研究院有限公司 一种抗衰老组合物及其应用
EP3251682A1 (fr) * 2014-12-30 2017-12-06 Procaps S.A. Compositions pour le traitement d'infections causées par l'acarien demodex spp

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03009995A (es) * 2001-05-09 2004-06-30 Univ Michigan Uso de composiciones para tratar rosacea.
US20050215635A1 (en) * 2004-03-08 2005-09-29 Rafi M Mohamed Diarylheptanoid compounds and uses thereof
BRPI0614162A2 (pt) * 2005-07-25 2016-11-22 Basf Ag dermocosmético, e, uso de um composto
CN101115493A (zh) * 2005-08-12 2008-01-30 河乃建仁 生发剂
JP2007186457A (ja) * 2006-01-13 2007-07-26 Ichimaru Pharcos Co Ltd トリプターゼ活性阻害剤およびその利用
KR101322495B1 (ko) * 2012-02-29 2013-10-28 경희대학교 산학협력단 로바릭산을 유효성분으로 포함하는 피부 미백용 조성물
WO2014037529A2 (fr) * 2012-09-07 2014-03-13 Analyticon Discovery Gmbh Composition antipelliculaire
CN106572967A (zh) * 2014-05-21 2017-04-19 奢弥联合化学有限公司 包含植物提取物的美白活性剂、其用途以及包含所述美白活性剂的组合物
KR102345428B1 (ko) * 2014-09-25 2022-01-03 주식회사 네이처인랩 극지 지의류 추출물을 함유하는 자외선 차단제 조성물 및 이를 함유하는 기능성 화장품
CN106039174A (zh) * 2016-07-07 2016-10-26 罗淇 一种治疗骨关节病的中药药酒
SE543379C2 (en) * 2018-12-21 2020-12-22 Oriflame Cosmetics Ag Composition and formulation comprising a Persicaria Capitata plant extract

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
US7105172B1 (en) * 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
US20030105031A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Methods for the treatment of skin disorders
US7381433B1 (en) * 2007-01-08 2008-06-03 Johnson & Johnson Consumer Companies, Inc. Compositions containing an extract of a primula denticulata and use thereof
EP3251682A1 (fr) * 2014-12-30 2017-12-06 Procaps S.A. Compositions pour le traitement d'infections causées par l'acarien demodex spp
CN106821865A (zh) * 2017-03-25 2017-06-13 广州市聚吉科绿色化学共性技术研究院有限公司 一种抗衰老组合物及其应用

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ABUBAKAR, I. B. et al "A Review on the Ethnomedicinal Uses, Phytochemistry and Pharmacology of Alpinia officinarum Hance". Journal of Ethnopharmacology. 2018, Vol. 224, pages 45-62 *
BASRI, A. M. et al "A Review on the Pharmacological Activies and Phytochemicals Alpinia officinarum (Galangal) Extracts Derieved from Bioassay-Guided Fractionation and Isolation". Pharmacognosy Reviews. 2017. Vol. 11, No. 27, pages 43-56 *
HONMORE, V. S. et al "Isolates of Alpinia officinarum Hance as COX-2 Inhibitors: Evidence from Anti-Inflammatory, Antioxidant and Molecular Docking Studies". International Immunophamacology. 2016, Vol. 33, pages 8-17 *
PILLAI, M. K. et al "Therapeutic Potential of Alpinia officinarum". Mini-Reviews in Medicinal Chemistry. 2018, Vol. 18, pages 1220-1232 *
RAJENDIRAN, V. et al "Anti-Inflammatory Activity of Alpinia officinarum Hance on Rat Colon Inflammation and Tissue Damage in DSS Induced Acute and Chronic Colitis Models". Food Science and Human Wellness. 2018, Vol. 7, pages 273-281 *
TWO, A. M. "Kallikrein 5-Mediated Inflammation in Rosacea, Clinically Relevant Correlations with Acute and Chronic Manifestations in Rosacea and How Individual Treatments May Provide Therapeutic Benefit". The Journal of Clinical Aesthetic Dermatology. 2014, Vol. 7, No. 1, pages 20-24 *

Also Published As

Publication number Publication date
SE1930415A1 (en) 2021-06-24
EP4081181A1 (fr) 2022-11-02
WO2021129977A1 (fr) 2021-07-01
CN115209868A (zh) 2022-10-18

Similar Documents

Publication Publication Date Title
EP2269621B1 (fr) Extrait de cinnamonum pour le traitement du photovieillissement
TWI355273B (en) Anti-aging preparation
Wölfle et al. Luteolin prevents solar radiation-induced matrix metalloproteinase-1 activation in human fibroblasts: a role for p38 mitogen-activated protein kinase and interleukin-20 released from keratinocytes
Valdes-Rodriguez et al. Transient receptor potential channels and dermatological disorders
KR20140109220A (ko) 산국 에센셜 오일을 유효성분으로 함유하는 피부 재생용 화장료 및 피부 외용제 조성물
KR20170048606A (ko) 증강된 항미생물 펩티드 및 단백질 수준과 관련된 피부 질환 또는 장애를 치료 또는 완화하기 위한 조성물
JP2015131838A (ja) パッシフロラ・アラタ（Ｐａｓｓｉｆｌｏｒａａｌａｔａ）の植物抽出物を調製するプロセス、並びに化粧品組成物及び医薬組成物における該抽出物の使用
US20140039204A1 (en) 7'-phloroeckol compound for hair proliferation and a cosmetic composition containing same
US10966911B2 (en) Melanin decomposition inhibitor
KR102302304B1 (ko) 2-푸코실락토오스를 포함하는 자가포식 활성 유도용 조성물
KR20130138590A (ko) 알로페론을 포함하는 항염증 약학적 조성물 및 화장료 조성물
US20170281500A1 (en) Vegfc production promoter
SE544843C2 (en) Plant extracts for treatment of rosacea
KR101484033B1 (ko) 땅콩 껍질 추출물을 포함하는 탈모방지 또는 발모촉진용 조성물
KR20200049714A (ko) 두충나무 껍질 추출물을 함유하는 피부 쿨링 또는 피부 홍조 완화용 화장료 조성물
KR20140091376A (ko) 국화 추출물을 포함하는 탈모방지 또는 발모촉진용 조성물
KR101947277B1 (ko) Tram-34를 함유하는 화상 후 비후성 반흔 형성 예방용 약학 조성물
Park et al. Effects of xanthium stramarium and psoralea corylifolia extracts combined with UVA1 irradiation on the cell proliferation and TGF-β1 expression of keloid fibroblasts
KR102477053B1 (ko) 자감초, 향부자 및 강황의 혼합 추출물을 유효성분으로 함유하는 화장료 조성물
KR101799426B1 (ko) 적하수오 추출물을 함유하는 화장품 조성물
KR102248259B1 (ko) 콩 식물세포 유래 엑소좀을 유효성분으로 포함하는 피부개선용 조성물
JP7471085B2 (ja) コレステロール合成促進剤
KR101874028B1 (ko) Sac 유도체 또는 smc 유도체를 포함하는 피부 미백용 조성물
ES2327525T3 (es) Uso de la quinquina para la preparacion de un medicamento que estimula la angiogenesis.
KR102646259B1 (ko) 칼펩틴을 함유하는 화상 후 비후성 반흔 형성 예방 또는 치료용 약학 조성물